Among 436 sporadic CRC patients with available blood DNA, germline mutation frequencies of hMLH1 and hMSH2 genes were 5.28% (23/436) and 10.78% (47/436), respectively (p<0.01) (Table 3). This evidence concerns the gene MLH1 and colorectal carcinoma.